GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (FRA:RMN) » Definitions » Future 3-5Y EPS without NRI Growth Rate

MediciNova (FRA:RMN) Future 3-5Y EPS without NRI Growth Rate : -11.37 (As of Sep. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is MediciNova Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, MediciNova's Future 3-5Y EPS without NRI Growth Rate is -11.37.


Competitive Comparison of MediciNova's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, MediciNova's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediciNova's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MediciNova's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where MediciNova's Future 3-5Y EPS without NRI Growth Rate falls into.



MediciNova  (FRA:RMN) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


MediciNova Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of MediciNova's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


MediciNova Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (FRA:RMN) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
Address
4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

MediciNova Headlines

No Headlines